Product Description
919958729793
Nintib 150 Mg Capsule, manufactured by Cipla Ltd, is highly recommended for its brilliant efficacy in managing idiopathic pulmonary fibrosis, non-small cell lung cancer, and systemic sclerosis-associated interstitial lung disease. Offered as a bargain promotion in a 10-capsule blister pack, this product epitomizes noble pharmaceutical advancements. With its targeted action as a Tyrosine Kinase Inhibitor, Nintib delivers immediate-release nintedanib 150 mg in a light yellow, oval-shaped soft gelatin form. Prescription-only and remarked for its quality, this capsule is a wise choice for healthcare professionals in India and beyond.
Nintib 150 Mg Capsule: Advanced Features and Versatile Applications
Nintib 150 Mg Capsule excels not only for its targeted anti-fibrotic and anti-cancer application but also for its immediate-release formula, enhancing therapeutic response. The product is available in secure, printed blister packs, ensuring easy identification and protection. Beyond its core applications, Nintib can be used in a range of clinical settings under medical supervision. The soft gelatin form and stable room temperature storage further highlight its convenience for both providers and patients.
Supply Capacity, Export Markets, and Sample Proposal for Nintib 150 Mg Capsule
Nintib 150 Mg Capsule is manufactured and exported from India, reaching global markets with efficient supply ability. Exchange opportunities are available for bulk orders, while proposal amounts and list prices are tailored to meet clients' needs. Cipla Ltd offers flexible sample policies to qualified partners, allowing healthcare professionals to familiarize themselves with the product before making procurement decisions. This makes Nintib an accessible and strategic option for distributors and healthcare suppliers worldwide.
FAQ's of Nintib 150 Mg Capsule:
Q: How should Nintib 150 Mg Capsule be administered?
A: Nintib 150 Mg Capsule should be taken orally as directed by a medical professional, following the prescribed dosage and schedule. Do not break, chew, or crush the capsule.
Q: What are the main indications for prescribing Nintib 150 Mg Capsule?
A: Nintib is prescribed for idiopathic pulmonary fibrosis, non-small cell lung cancer, and systemic sclerosis-associated interstitial lung disease, as an anti-fibrotic and anti-cancer agent.
Q: When should Nintib 150 Mg Capsule be stored and where?
A: Store Nintib 150 Mg Capsule below 30C, in a dry location and within its original protective blister pack to maintain its potency and integrity.
Q: Where is Nintib 150 Mg Capsule manufactured and available for export?
A: Nintib 150 Mg Capsule is manufactured by Cipla Ltd in India and is exported to various regions worldwide as per demand and regulatory compliance.
Q: What benefits does Nintib 150 Mg Capsule offer over other treatment options?
A: Nintib offers a targeted approach as a Tyrosine Kinase Inhibitor, providing rapid symptom management and a favorable safety profile when used as prescribed, making it highly regarded among healthcare professionals.
Q: How can I request a sample or initiate a purchase proposal for Nintib 150 Mg Capsule?
A: Interested parties can contact the supplier or manufacturer to discuss a sample policy, and proposal amounts or negotiate list prices for bulk procurement and distribution.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese